Clinical Trials Directory

Trials / Terminated

TerminatedNCT01800097

Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent

Treatment of Post Stroke Fatigue With Modafinil, Effect on Rehabilitation, Fatigue and Bonemass Index

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Herlev Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is an investigator initiated placebo controlled double blinded trial. The hypothesis is that treatment with modafinil positively will affect behavioural and cognitive rehabilitation after stroke, causing the treatment group to experience decreased fatigue, increased endurance, improved skills of sustaining attention and faster reaction times. The cognitive rehabilitation will show in increased muscle mass, decreased osteoporosis and better physical performances due to a higher level of physical activity.

Conditions

Interventions

TypeNameDescription
DRUGmodafinilTablet, 400 mg once daily, morning (200 mg if age 65 or above) for 3 months
DRUGplaceboTablets, 400 mg once daily ( 200 mg if age 65 or above)morning for 3 months.

Timeline

Start date
2012-10-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2013-02-27
Last updated
2015-06-24

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01800097. Inclusion in this directory is not an endorsement.

Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent (NCT01800097) · Clinical Trials Directory